Table of contents
1. Introduction
1.1 Definition
1.2 scope of study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2. Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3. Market dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4. Market factor analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5. Global Ureteral Obstruction Market, by Type
5.1 Acute
5.2 Chronic
6. Global Ureteral Obstruction Market, By Diagnosis
6.1 Ultrasound
6.2 Computed Tomography (CT)
6.3 Magnetic Resonance Imaging (MRI)
6.4 Voiding Cystourethrography (VCUG)
6.5 Pyelography
6.6 Endoscopy
6.7 Blood and Urine Tests
6.8 Bladder Catheterization
6.9 Others
7. Global Ureteral Obstruction Market, By Treatment
7.1 Surgery
7.1.1 Ureteral Stent
7.1.2 Nephrostomy
7.1.3 Open Laparoscopy
7.1.4 Catheterization
7.1.5 Robot-Assisted Laparoscopy
7.1.6 Others
7.2 Drugs
7.2.1 Antibiotics
7.2.2 Pain Killers
7.2.3 Others
7.4 Others
8. Global Ureteral Obstruction Market, By Equipment
8.1 Devices
8.1.1 Catheters
8.1.2 Stents
8.1.3 Others
8.2 Consumables
8.2.1 Diagnostic Reagents
8.2.2 Urinary Sample Collectors
8.2.3 Others
8.3 Others
9. Global U reteral Obstruction Market, By End Users
9.1 Hospitals and Clinics
9.2 Research
9.3 Home Care
10. Global Ureteral Obstruction Market, By Region
10.1 North America
10.1.1 Introduction
10.2 Europe
10.2.1 Introduction
10.3 Asia-Pacific
10.3.1 Introduction
10.4 Middle East & Africa
10.4.1 Introduction
11. Competitive landscape
11.1 Major Strategies Adopted By Market Players
11.1.1 Strategic Partnership
11.1.2 Merger & Acquisition
12. Company profile
12.1 C. R. Bard, Inc.
12.1.1 Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 Key Developments
12.2 Boston Scientific Corporation
12.2.1 Overview
12.2.2 Product Overview
12.2.3 Financials
12.2.4 Key Developments
12.3 Cook Medical Inc.
12.3.1 Overview
12.3.2 Product Overview
12.3.3 Financials
12.3.4 Key Development
12.4 Medline Industries, Inc.
12.4.1 Overview
12.4.2 Product Overview
12.4.3 Financials
12.4.4 Key Developments
12.5 Coloplast A/S
12.5.1 Overview
12.5.2 Product Overview
12.5.3 Financials
12.5.4 Key Developments
12.6 DISA Vascular
12.6.1 Overview
12.6.2 Product Overview
12.6.3 Financials
12.6.4 Key Developments
12.7 Terumo Europe NV
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.8 Medtronic
12.8.1 Overview
12.8.2 Product Overview
12.8.3 Financials
12.8.4 Key Developments
12.9 Novartis AG
12.9.1 Overview
12.9.2 Product Overview
12.9.3 Financials
12.9.4 Key Developments
12.10 Johnson and Johnson
12.10.1 Overview
12.10.2 Product Overview
12.10.3 Financials
12.10.4 Key Developments
12.11 Other
13. Conclusion
13.1 Key Findings
13.1.1 From Ceo’s Viewpoint
13.1.2 Unmet Needs Of The Market
13.2 Key Companies To Watch
13.3 Prediction Of Ureteral Obstruction Treatment Industry
14. Appendix
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
